Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,627,689 papers from all fields of science
Search
Sign In
Create Free Account
Cilengitide
Known as:
cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl)
A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Angiogenesis Inhibition
Cell Adhesion Inhibition
Endothelium, Vascular
Integrin Inhibition
Expand
Narrower (1)
EMD 121974
Broader (1)
Snake Venoms
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effects of dopaminergic pathways on human neutrophil
Monica Pinoli
2016
Corpus ID: 90135539
2015
2015
Cancer Cell Enhancing Chemotherapy Delivery and Efficacy drug
Ping-Pui Wong
,
F. Demircioglu
,
+10 authors
K. Hodivala-Dilke
2015
Corpus ID: 207872927
Ping-Pui Wong,1 Fevzi Demircioglu,1 Essam Ghazaly,2 Wasfi Alrawashdeh,3 Michael R.L. Stratford,5 Cheryl L. Scudamore,6…
Expand
2015
2015
Peptide-Based Cancer Therapeutics | Articles | drug development and delivery back issues | Drug Development & Delivery
2015
Corpus ID: 21838148
Dr. Jyothi Thundimadathil is a Technical Marketing Associate at American Peptide Company Inc. He has more than 10 years of…
Expand
2014
2014
Emergence of Biologics in Cancer Treatment
2014
Corpus ID: 30352821
Over the years, peptides have been evolved as promising therapeutic agents in the treatment of cancer, diabetes, and…
Expand
2012
2012
ROLE OF INTEGRINS IN CANCER DEVELOPMENT – THERAPEUTIC
INTEGRINų Vaidmuo
,
VėžIO Atsiradime
,
IR jO GyDyME
,
J. Lazowski
2012
Corpus ID: 53388044
2011
2011
Chemotherapie bei Gliomen
W. Wick
,
F. Winkler
,
M. Platten
Der Onkologe
2011
Corpus ID: 2928468
ZusammenfassungAktuelle Strategien der Primärtherapie von Gliomen zielen auf eine Ergänzung der kombinierten Radiochemotherapie…
Expand
2011
2011
Understanding the Clinical Applicability of Integrin Inhibition in the Treatment of Glioblastoma Learning
D. Reardon
,
M. Chamberlain
2011
Corpus ID: 49482674
2010
2010
Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study.
L. Nabors
,
K. Fink
,
+6 authors
T. Mikkelsen
2010
Corpus ID: 74498693
TPS151 Background: Expected median survival is poor for patients with glioblastoma multiforme (GBM). Cilengitide, an…
Expand
2010
2010
Safety of different regimens of the novel integrin inhibitor cilengitide combined with cetuximab and platinum-based chemotherapies.
J. Vansteenkiste
,
T. Brümmendorf
,
+6 authors
J. Vermorken
2010
Corpus ID: 73862632
e18067 Background: Cilengitide is an investigational selective αvβ3/5 integrin inhibitor in clinical development for advanced non…
Expand
2008
2008
Cilengitide in asymptomatic metastatic androgen independent prostate cancer (AIPC) patients (pts): A randomized phase II trial
D. Bradley
,
S. Daignault
,
+7 authors
M. Hussain
2008
Corpus ID: 74641944
5144 Background: Integrins αvβ3 and αvβ5 are involved in PC metastasis by regulating cell adhesion, migration, invasion, motility…
Expand